Tyra Biosciences Inc.
TYRA | NASDAQ
$25.44
-$0.21 (-0.82%)
Sep 22, 2026, 2:14 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | 47K |
Gross Profit | n/a | n/a | n/a | n/a | n/a | -47K |
Operating Income | -132.76M | -104.18M | -79.95M | -58.93M | -26.29M | -9.3M |
Interest Income | 12.82M | 17.7M | 10.81M | 3.65M | 13K | n/a |
Pretax Income | -119.95M | -86.48M | -69.13M | -55.33M | -26.29M | -9.34M |
Net Income | -119.95M | -86.48M | -69.13M | -55.33M | -26.29M | -9.31M |
Selling & General & Admin | 29.83M | 24.1M | 17.43M | 15.92M | 5.65M | 2.09M |
Research & Development | 102.93M | 80.08M | 62.52M | 43.01M | 20.64M | 7.2M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | -23K |
Operating Expenses | 132.76M | 104.18M | 79.95M | 58.93M | 26.29M | 9.25M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | 1K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 132.76M | 104.18M | 79.95M | 58.93M | 26.29M | 9.3M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 59.6M | 57.22M | 42.7M | 41.88M | 41.44M | 42.54M |
Shares Outstanding (Diluted) | 59.6M | 57.22M | 42.7M | 41.88M | 41.44M | 42.54M |
EPS (Basic) | -2.01 | -1.51 | -1.62 | -1.23 | -0.63 | -0.22 |
EPS (Diluted) | -2.01 | -1.51 | -1.62 | -1.23 | -0.63 | -0.22 |
EBITDA | -119.4M | -85.96M | -68.78M | -55.03M | -26.15M | -9.25M |
EBIT | -119.95M | -86.48M | -69.13M | -55.33M | -26.29M | -9.34M |
Depreciation & Amortization | 546K | 519K | 357K | 296K | 140K | 47K |
Add to Watchlist
Select watchlists to add or remove TYRA